Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schroeder Theodore R
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   22,996    

Indirect Shares

   117,489      
Direct Value   $369,493    

Indirect Value

   $46,267      
Total Shares   140,485      
Total Value   $415,760      


Collegium Pharmaceutical, Inc $364,772 Nabriva Therapeutics AG $4,721 Collegium Pharmaceutical, Inc $364,772 Nabriva Therapeutics AG $4,721
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -100.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cadence Pharmaceuticals Inc CADX President, CEO, Director 2014-03-19 0 2014-03-19 0    Premium*  
            Hyperion Therapeutics Inc HPTX Director 2015-05-07 0 2014-08-13 0    Premium*  
            Collegium Pharmaceutical, Inc COLL Director 2020-05-20 11,007 2018-05-24 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2023-01-29 11,989 2019-08-27 117,489    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-07-31 4 D $1.10 $118 D/D (107) 177,432 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-07-06 4 D $1.27 $286 D/D (225) 177,539 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-06-30 4 D $1.35 $144 D/D (107) 177,764 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-06-06 4 D $1.34 $302 D/D (225) 177,871 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-05-31 4 D $1.38 $148 D/D (107) 178,096 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-05-06 4 D $1.49 $335 D/D (225) 178,203 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-04-30 4 D $1.78 $190 D/D (107) 178,428 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-04-06 4 D $1.73 $389 D/D (225) 178,535 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-03-06 4 D $1.79 $403 D/D (225) 178,760 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-02-06 4 D $2.90 $7,816 D/D (2,695) 178,985 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-03-31 4 D $1.66 $178 D/D (107) 181,680 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-02-28 4 D $2.39 $253 D/D (106) 181,787 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-01-31 4 D $2.62 $328 D/D (125) 181,893 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-01-29 4 A $0.00 $0 D/D 117,500 182,018 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-12-06 4 D $0.72 $162 D/D (225) 225,879 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-11-30 4 D $0.78 $83 D/D (107) 226,104 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-11-06 4 D $1.33 $299 D/D (225) 226,211 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-10-06 4 D $1.08 $243 D/D (225) 226,543 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-09-30 4 D $1.19 $127 D/D (107) 226,768 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-09-14 4 B $1.13 $56,500 D/D 50,000 226,875 2.81 %
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-11-11 5 GD $0.00 $0 I/I 19,500 291,500 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-01-31 4 D $1.35 $21,973 D/D (16,276) 302,760 0 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2011-05-17 4 B $7.48 $119,626 I/I 16,000 307,500 2.66 -
CADX Cadence Pharmaceuticals I... President, CEO   •       •      –    2010-10-01 4 AS $8.35 $77,670 I/I (9,297) 311,000 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-09-06 4 D $0.16 $35 D/D (225) 311,977 0 -
  90  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us